A novel saline-based occlusion tool allows for dye-less cryoballoon-based pulmonary vein isolation and fluoroscopy reduction.

Background: Cryoballoon (CB)- based pulmonary vein isolation (PVI) remains guided by fluoroscopy and dye. The novel saline injection-based occlusion tool allows for pulmonary vein (PV)-occlusion assessment without the need for dye injection.

Aim: To compare KODEX-EPD guided CB-PVI using the novel saline injection-based workflow with conventional cryoablation for acute efficacy, fluoroscopy exposure and dye volume.

Methods: Consecutive atrial fibrillation (AF)- patients undergoing CB-PVI in conjunction with KODEX-EPD (Cryo group) were analyzed. Patients undergoing conventional CB-PVI (Cryo group) in the same time period acted as controls.

Results: One hundred forty patients [91/140 (65%) persistent AF] were studied. Seventy patients underwent Cryo procedures [64 ± 13 years, 21 (30%) female] and seventy patients underwent Cryo procedures [68 ± 10 years, 27 (39%) female].A total of 560 PVs were identified and successfully isolated. Mean procedure time was 66 ± 15 min for the Cryo group, and 65 ± 19 min for the Cryo group ( = 0.3). Fluoroscopy time (Cryo 6 ± 4 min; Cryo 13 ± 6 min,  < 0.001) and dose area product (Cryo 193 [111; 297] cGycm; Cryo 381 [268; 614] cGycm,  < 0.001) were lower in patients undergoing Cryo compared with Cryo procedures. No dye was needed in the Cryo group while 53 ± 18 ml dye per patient were administered for the Cryo group ( < 0.001). The overall complication rate was comparable between both groups ( = 0.5).

Conclusion: KODEX-EPD guided AF-ablation enables dye-free CB-based PVI with reduced fluoroscopy exposure when compared to conventional CB-ablation, without differences in acute procedural outcomes or procedure duration.